Vaccines for Children 2024-2025

UPDATE 02/05/2024: The answers to the vendor questions received by the question deadline have been attached to this posting. The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration: Dengue vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax:

N/A Maximum:

50K Doses Minimum: 100 Doses DTaP vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $2.25 per dose Maximum:

6.5M Doses Minimum: 100 Doses DTaP/Hep B/IPV vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $3.75 per dose Maximum:

5.38M Doses Minimum: 100 Doses DTaP-IPV vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $3.00 per dose Maximum:

3.5M Doses Minimum: 100 Doses DTaP-IP-HIB vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $3.75 per dose Maximum:

7.5M Doses Minimum: 100 Doses DTaP-IPV-HIB-HEPB vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $4.50 per dose Maximum:

3M Doses Minimum: 100 Doses E-IPV vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

4M Doses Minimum: 100 Doses Hepatitis A (pediatric) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

8.5M Doses Minimum: 100 Doses Hepatitis A&B (Age 18 only) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $1.50 per dose Maximum:

100K Doses Minimum: 100 Doses Hepatitis B (pediatric/adol.) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

7.7M Doses Minimum: 100 Doses Hib vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

8M Doses Minimum: 100 Doses Human Papillomavirus vaccine, Recombinant Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

9M Doses Minimum: 100 Doses Measles, Mumps & Rubella (MMR) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $2.25 per dose Maximum:

8M Doses Minimum: 100 Doses Meningococcal Conjugate (MCV4) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

6.5M Doses Minimum: 100 Doses Meningococcal Conjugate- Serogroup B Meningococcal vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $1.50 per dose Maximum:

750K Doses Minimum: 100 Doses Mpox vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax:

TBD Maximum:

125K Doses Minimum: 100 Doses Pneumococcal Conjugate vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

13M Doses Minimum: 100 Doses Pneumococcal (23 Valent) Polysaccharide vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax:

N/A Maximum:

350K Doses Minimum: 100 Doses Rotavirus vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

7M Doses Minimum: 100 Doses Respiratory Syncytial Virus vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax:

TBD Maximum:

2.5M Doses Minimum: 100 Doses Tetanus and Diphtheria (Td) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $1.50 per dose Maximum:

750K Doses Minimum: 100 Doses Tdap vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $2.25 per dose Maximum:

5.5M Doses Minimum: 100 Doses Varicella vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

10M Doses Minimum: 10 Doses Measles, Mumps & Rubella and Varicella (MMR-V) vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $3.00 per dose Maximum:

3.4M Doses Minimum: 10 Doses Serogroup B Meningococcal vaccine Min.

Shelf Life: 12 Months Fed.

Excise Tax: $0.75 per dose Maximum:

2.5M Doses Minimum: 100 Doses The vaccines awarded under these contracts will be purchased for and by NCIRD's Immunization Awardees to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B.

Destination to the 50 states and U.S. Territories. The period of performance shall be 4/1/2024 – 3/31/2025. Any questions regarding this notice shall be submitted in writing to William O'Bryan at rvq0@cdc.gov by 5:00 PM Eastern Time on February 2, 2024. Telephone inquiries will not be honored.